« Previous Next » International Journal of Gynecology & Obstetrics
Volume 85, Issue 3 , Pages 292-293 , June 2004

Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia

E.B Kilicdag
- Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Baskent, Turkey
- Corresponding author. Obstetrics and Gynecology Department, Yurt Mahalle, 229 Sok Hakan Burak Apt Kat: 2 Daire: 4, Seyhan-Adana, Turkey. Tel.: +90-532-673-5754; fax: +90-322-327-1273
E Tarim
- Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Baskent, Turkey
T Bagis
- Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Baskent, Turkey
S Erkanli
- Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Baskent, Turkey
E Aslan
- Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Baskent, Turkey
K Ozsahin
- Department of Endocrinology and Metabolism, Baskent University Faculty of Medicine, Baskent, Turkey
E Kuscu
- Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Baskent, Turkey

Received 15 December 2003 ,Revised 7 January 2004 ,Accepted 7 January 2004.

References

Josimovich JB, Lavenhar MA, Devanesan MM, Sesta HJ, Wilchins SA, Smith AC. Herterogeneous distribution of serum prolactin values in apparently healthy young women, and the effects of oral contraceptive medication. Fertil Steril. 1987;47:785–791
- MEDLINE
Peters F, Schuth W, Scheurich B, Breckwoldt M. Serum prolactin levels in patients with fibrocystic breast disease. Obstet Gynecol. 1984;64(3):381–385
- MEDLINE
Biller BM, Luciano A, Crosignani PG, Molitch M, Olive D, Rebar R, et al. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med. 1999;44(12 Suppl):1075–1084
- MEDLINE
Mah PM, Webster J. Hyperprolactinemia: etiology, diagnosis, and management. Semin Reprod Med. 2002;20(4):365–374
- MEDLINE
- CrossRef